摘要
目的观察前列地尔联合生长抑素治疗重症急性胰腺炎的临床疗效。方法将68例重症急性胰腺炎患者随机分为生长抑素治疗组(对照组,32例)和前列地尔+生长抑素治疗组(观察组,36例)。比较两组患者症状、腹部体征消失时间、血淀粉酶恢复正常的时间。结果观察组、对照组的有效率分别为94.44%、65.63%。两组疗效比较差异有统计学意义,P<0.05。结论前列地尔联合生长抑素治疗重症急性胰腺炎安全有效。
Objective To investigate the effect of alprostadil combined with somatostatin on severe acute pan-creatitis. Methods 68 patients with severe acute pancreatitis were divided into 2 groups：control group （32 cases）was treated with somatostatin ; treatment group （ 36 cases ） was treated with alprostadil combined with somatostatin. The symptoms, signs, AMS in serum of the two groups were observed and compared. Results The effective rates of treat- ment group and control group were 94. 44 % and 65.63 % respectively, there was obvious difference between the two groups （ P 〈 0.05 ）. Conclusion Alprostadil combined with somatostatin is safe and effective to treat severe acute pan- creatitis.
出处
《实用药物与临床》
CAS
2013年第1期20-21,共2页
Practical Pharmacy and Clinical Remedies
